loading

Nuvectis Pharma Inc Aktie (NVCT) Neueste Nachrichten

pulisher
Oct 10, 2025

Technical analysis overview for Nuvectis Pharma Inc. stockJuly 2025 Fed Impact & Consistent Profit Trading Strategies - newser.com

Oct 10, 2025
pulisher
Oct 10, 2025

Nuvectis Pharma (NASDAQ:NVCT) Given Sell (E+) Rating at Weiss Ratings - MarketBeat

Oct 10, 2025
pulisher
Oct 10, 2025

Using flow based indicators on Nuvectis Pharma Inc.Oil Prices & Long-Term Growth Stock Strategies - newser.com

Oct 10, 2025
pulisher
Oct 06, 2025

Applying Wyckoff theory to Nuvectis Pharma Inc. stockNew Guidance & Smart Allocation Stock Reports - newser.com

Oct 06, 2025
pulisher
Oct 05, 2025

Published on: 2025-10-05 01:41:39 - newser.com

Oct 05, 2025
pulisher
Oct 03, 2025

Price momentum metrics for Nuvectis Pharma Inc. explained2025 Key Lessons & Weekly Top Stock Performers List - newser.com

Oct 03, 2025
pulisher
Oct 03, 2025

Using economic indicators to assess Nuvectis Pharma Inc. potential2025 Performance Recap & AI Powered Buy and Sell Recommendations - newser.com

Oct 03, 2025
pulisher
Oct 03, 2025

How to use Fibonacci retracement on Nuvectis Pharma Inc.Market Growth Review & Low Drawdown Investment Ideas - newser.com

Oct 03, 2025
pulisher
Oct 03, 2025

Momentum divergence signals in Nuvectis Pharma Inc. chartJuly 2025 Recap & Expert Approved Momentum Trade Ideas - newser.com

Oct 03, 2025
pulisher
Oct 02, 2025

Using portfolio simulators with Nuvectis Pharma Inc. includedEarnings Growth Summary & Long-Term Safe Return Strategies - newser.com

Oct 02, 2025
pulisher
Sep 28, 2025

Nuvectis Pharma Inc Stock Analysis and ForecastMarket Rumors and News & Market Trend Real-Time Reports - earlytimes.in

Sep 28, 2025
pulisher
Sep 27, 2025

Goldman Sachs Group Inc. Takes $446,000 Position in Nuvectis Pharma, Inc. $NVCT - MarketBeat

Sep 27, 2025
pulisher
Sep 27, 2025

What drives Nuvectis Pharma Inc stock priceTrading Volume Trends & Small Budget Trading Ideas - Early Times

Sep 27, 2025
pulisher
Sep 27, 2025

Nuvectis Pharma (NASDAQ:NVCT) Shares Up 2.2%Time to Buy? - MarketBeat

Sep 27, 2025
pulisher
Sep 27, 2025

Nuvectis Pharma (NASDAQ:NVCT) Shares Up 2.2% – Time to Buy? - Defense World

Sep 27, 2025
pulisher
Sep 26, 2025

Nuvectis Pharma Appoints Juan Sanchez to Board - The Globe and Mail

Sep 26, 2025
pulisher
Sep 26, 2025

Nuvectis Pharma adds former Intra-Cellular exec to board of directors - Investing.com Nigeria

Sep 26, 2025
pulisher
Sep 25, 2025

Nuvectis Pharma adds former Intra-Cellular exec to board of directors By Investing.com - Investing.com South Africa

Sep 25, 2025
pulisher
Sep 25, 2025

Nuvectis Pharma Appoints Juan Sanchez, MD, To Board - citybiz

Sep 25, 2025
pulisher
Sep 25, 2025

Nuvectis Pharma Appoints Biotech Executive Juan Sanchez, MD, to the Board of Directors - GlobeNewswire

Sep 25, 2025
pulisher
Sep 25, 2025

From $14.6B J&J Deal Success: Nuvectis Pharma Adds Key Biotech Executive to Board Ahead of Phase 1b Trial - Stock Titan

Sep 25, 2025
pulisher
Sep 23, 2025

Is Nuvectis Pharma Inc. forming a reversal pattern2025 Pullback Review & Short-Term Trading Opportunity Alerts - newser.com

Sep 23, 2025
$21.35
price down icon 5.74%
$83.80
price down icon 1.12%
$31.81
price down icon 0.13%
$102.06
price down icon 2.32%
$162.33
price down icon 1.26%
biotechnology ONC
$320.10
price down icon 4.68%
Kapitalisierung:     |  Volumen (24h):